| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
|
| | Ficlatuzumab Basic information |
| Product Name: | Ficlatuzumab | | Synonyms: | Ficlatuzumab;Research Grade Ficlatuzumab(DHD03701);Ficlatuzumab (anti-HGF);Research Grade Ficlatuzumab | | CAS: | 1174900-84-5 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Ficlatuzumab Structure]() |
| | Ficlatuzumab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Ficlatuzumab Usage And Synthesis |
| Uses | Ficlatuzumab is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion[1]. | | References | [1] Kumar D, et al. Mitigation of Tumor-Associated Fibroblast-Facilitated Head and Neck Cancer Progression With Anti-Hepatocyte Growth Factor Antibody Ficlatuzumab. JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1133-9. DOI:10.1001/jamaoto.2015.2381 |
| | Ficlatuzumab Preparation Products And Raw materials |
|